Fuertes, Thelma C.
HRN: 22-58-63 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/06/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
05/06/2025
05/13/2025
IV
300 Mg
Q6hrs
Infected Wound Left Foot; DM Foot
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes